Skip to main content
Medicine logoLink to Medicine
. 2023 Jun 16;102(24):e33993. doi: 10.1097/MD.0000000000033993

eNOS polymorphisms on male infertility: An updated systematic review and meta-analysis

Zhihai Teng a, Hu Wang a, Fengran Guo a, Zhenwei Han a, Yaxuan Wang a,*
PMCID: PMC10270503  PMID: 37327284

Background:

This meta-analysis was performed to examine the association of 3 endothelial nitric oxide synthase (eNOS) gene polymorphisms with male infertility.

Methods:

The literature on the relation between the mutant of eNOS and male infertility before July 1, 2022, was conducted in Pubmed, Medline, and Web of Science. The search strategy is as follows: (eNOS OR ECNOS OR nitric oxide synthase 3 OR NOS3) AND (polymorphism OR mutation OR variation OR SNP OR genotype) AND (male infertility). Statistical analysis was performed with the web of MetaGenyo, Stata 12, trial sequential analysis 0.9Beta, and the web of GTEx.

Results:

Overall, 13 studies (26 case-controls) were included involving 6518 cases and 5461 controls for 3 polymorphisms (rs2070744, rs1799983, rs61722009) of eNOS. We found that eNOS rs2070744 was correlated with an increased risk of male infertility (C vs. T: odds ratio [OR], 1.48; 95% confidence interval [CI], [1.19–1.85]; CC vs. TT: OR, 2.59; 95% CI, [1.40–4.80]; CT vs. TT: OR, 1.17; 95% CI, [1.00–1.38]; CC vs. CT + TT: OR, 2.50; 95% CI, [1.35–4.62]; CC + CT vs. TT: OR, 1.41; 95% CI, [1.21–1.64]). And eNOS rs1799983 was correlated with an increased risk of male infertility (allele contrast T vs. G: OR, 1.41; 95% CI, [1.01–1.96]; P = .043; recessive model TT vs. TG + GG: OR, 2.00; 95% CI, [1.03–3.90]; P = .042). In the stratified analysis of rs61722009, we found Asians might be correlated with an increased risk of male infertility (4a vs. 4b: OR, 1.50; 95% CI, [0.94–2.38]; 4a4a vs. 4b4b: OR, 2.56; 95% CI, [0.70–9.38]; 4a4b vs. 4b4b: OR, 1.36; 95% CI, [0.87–2.13]; 4a4a vs. 4a4b + 4b4b: OR, 2.57; 95% CI, [0.91–7.30]; 4a4a + 4a4b vs. 4b4b: OR, 1.44; 95% CI, [0.87–2.40]).

Conclusion:

The eNOS rs2070744 polymorphism and rs1799983 are associated with the risk of male infertility, and rs61722009 might be a risk factor for Asians.

Keywords: eNOS, male infertility, meta-analysis, polymorphism, SNP

1. Introduction

Male infertility has significantly impacted 10 to 15% of the world’s couples and has gradually become a common disease.[1] The trouble in the relations and the community is raised. There are several factors for male infertility, including environmental changes and genetic mutations,[2,3] among others. And these factors have a negative impact on sperm function.[4] Previous studies have identified three types of male infertility including azoospermia, asthenozoospermia, and oligozoospermia.

Oxidative stress is a significant problem linked to sperm dysfunction, affecting sperm motility and asthenozoospermia.[5] Nitrogen oxide (NO) is a reactive free radical gas with diverse functions, acting as a messenger in numerous biological processes.[6] Previously studies have demonstrated that NO is synthesized by human male gametes and plays a role in mammalian reproduction and sexual function.[7,8] However, excessive concentrations of NO can lead to dysfunction, while low concentrations of NO play a crucial role in spermatozoon physiology.[9]

NO is mainly produced by nitric oxide synthase (NOS) by the conversion of L-arginine to L-citrulline.[10] NOS consists of 3 isoforms: endothelial NOS (eNOS), inducible NOS, and neuronal NOS.[11] The eNOS is the main enzyme to produce NO. The eNOS gene contains 3 common single nucleotide polymorphisms known as rs2070744, rs1799983, and rs6172009. Studies have shown that these eNOS polymorphisms are associated with oxidative stress in various clinical conditions, including pre-eclampsia, persistent obstructive pulmonary disorders, diabetic nephropathy, and others.[12,13]

In recent years, several randomized controlled trials have been conducted to investigate the association between male infertility and the polymorphisms of eNOS, and a few meta-analyses were used to verify the results. Due to limitations in sample sizes, the findings of these studies have been inconsistent. So we provided a comprehensive review to examine the associations between them.

2. Methods

2.1. Literature search

We conducted a comprehensive literature search on PubMed, Medline, and Web of Science up to July 1, 2022, to investigate the potential association between eNOS polymorphisms and male infertility risk. Our search strategy included the terms “eNOS,” “ECNOS,” “nitric oxide synthase 3,” “NOS3,” “polymorphism,” “mutation,” “variation,” “SNP,” “genotype,” and “male infertility,” and we only included studies published in English. Following a meticulous screening process, we identified 3 eNOS polymorphisms (rs2070744, rs1799983, and rs6172009) for further investigation. We conducted a comprehensive review of the selected studies, ensuring their high quality and relevance to our research question.

2.2. Inclusion criteria and exclusion criteria

Our meta-analysis followed a set of inclusion and exclusion criteria for selecting articles. We included case-control studies that investigated the association between eNOS polymorphisms and cancer risk, as well as population genetic polymorphism publications. Additionally, we incorporated articles that provided sufficient genotype data, allowing us to estimate odds ratios (ORs) and corresponding 95% confidence intervals (CIs). We also required that control subjects satisfied Hardy–Weinberg equilibrium (HWE). We excluded case-only studies, case reports, or reviews, studies without raw data for eNOS genotypes, and studies that combined other influencing factors. By applying these criteria, our aim is to ensure that the studies included in our meta-analysis were of high quality and directly relevant to our research objectives.

2.3. Data extraction

Two researchers obtained the data independently, following the selection criteria outlined above, and any discrepancies were resolved through consensus. The data extracted from the eligible articles included the first author’s name, publication year, ethnicity, source of control, and the number of cases and controls with eNOS genotypes. Ethnicity was categorized into 3 groups: “Mixed,” “Caucasian,” and “Asian.” These data were carefully collected and will be used in our subsequent analysis to assess the potential association between eNOS polymorphisms and disease risk. Our rigorous data collection process ensures the reliability and accuracy of our meta-analysis

2.4. Statistical analysis

Aggregate ORs and corresponding 95% CIs were calculated to assess the association between eNOS polymorphism and cancer risk, using allelic (B vs. A), homozygote (BB vs. AA), heterozygote (BA vs. AA), dominant (BA + BB vs. AA), and recessive (BB vs. BA + AA) models (A = wild allele; B = mutated allele). The heterogeneity between studies was evaluated using the Cochrane Q-statistic test, and the unreliability was quantified using the I2 statistic. A random effects model was used if I2 > 50% or PQ ≤ 0.1, indicating substantial heterogeneity, otherwise, a fixed effects model was applied. Subgroup meta-analysis was performed by ethnicity and the source of control. Sensitivity analysis was also conducted by omitting 1 study each time to assess the stability of the results. The HWE was estimated using the asymptotic test, and deviation was considered when P < .05. The potential publication bias of the eligible studies was quantitatively evaluated using the Egger regression test. Statistical analysis was performed using Stata 12.0 software (version 12.0; State Corporation, College Station, TX) and the web of MetaGenyo (https://metagenyo.genyo.es/).[14] A 2-tailed P < .05 was considered statistically significant.

2.5. In-silico analysis using GTEx website

For the purpose of investigating the influence of polymorphisms on eNOS, we obtained the association between the polymorphism and eNOS expression level using the GTEx cohort.[15]

2.6. Trial sequential analysis (TSA)

TSA was performed to reduce random errors and strengthen the robustness of our decisions.[16]

3. Results

3.1. Main characteristics of the enrolled studies

The study selection process is presented in Figure 1. In total, 9 articles were included for the eNOS gene polymorphism rs2070744, with a total of 2015 cases and 1676 controls. All of the included studies were found to be in accordance with HWE. For rs1799983, 12 studies with 2780 cases and 2319 controls were included, but 3 of the studies were found to be not in compliance with HWE. For rs61722009, 6 studies with 1723 cases and 1466 controls were included, and all of the included studies had HWE P values > .05. Table 1 presents the characteristics of the included studies, along with the genotype frequency distributions for the 3 polymorphisms.

Figure 1.

Figure 1.

Flow chart of studies selection process for eNOS gene polymorphisms. eNOS = endothelial nitric oxide synthase.

Table 1.

Characteristics of eligible case-control studies included in the meta-analysis.

SNP First author Year Ethnicity Source of Control Case Control HWE
CC CT TT CC CT TT
rs2070744 Bianco 2013 Mixed HB 38 93 77 25 97 79 Y
Faure 2014 Caucasian HB 7 27 18 3 14 17 Y
Mostafa 2015 Caucasian HB 66 72 82 3 36 41 Y
Mousavi 2020 Caucasian HB 7 47 46 7 37 56 Y
Safarinejad 2010 Caucasian HB 109 130 113 29 170 157 Y
Song 2015 Asian PB 3 46 261 2 38 268 Y
Vucic 2017 Caucasian PB 6 16 25 11 63 57 Y
Ying 2013 Asian PB 0 81 274 0 32 214 Y
Yun 2008 Asian PB 7 73 291 1 41 178 Y
TT TG GG TT TG GG
rs1799983 Bianco 2013 Mixed HB 110 73 25 97 93 23 Y
Buldreghini 2010 Caucasian HB 31 22 17 9 9 42 N
Chavoshi 2020 Caucasian HB 0 30 20 5 15 30 Y
Faure 2014 Caucasian HB 5 18 29 12 16 6 Y
Mostafa 2015 Caucasian HB 62 77 81 2 38 40 N
Muti 2014 Caucasian PB 7 10 12 8 20 20 Y
Safarinejad 2010 Caucasian HB 46 150 156 2 93 261 N
Song 2015 Asian PB 3 71 236 1 61 250 Y
Vucic 2017 Caucasian PB 14 60 57 12 53 66 Y
Yan 2014 Asian HB 14 154 410 7 127 435 Y
Ying 2013 Asian PB 10 96 249 4 66 176 Y
Yun 2008 Asian PB 1 53 371 0 25 195 Y
4a4a 4a4b 4b4b 4a4a 4a4b 4b4b
rs61722009 Bianco 2013 Mixed HB 127 66 15 124 69 8 Y
Safarinejad 2010 Caucasian HB 45 150 157 3 92 261 Y
Song 2015 Asian PB 2 57 247 1 34 277 Y
Vucic 2017 Caucasian PB 6 33 92 3 39 89 Y
Ying 2013 Asian PB 7 64 284 2 27 217 Y
Yun 2008 Asian PB 6 72 293 2 41 177 Y

HB = hospital-based, HWE = Hardy–Weinberg equilibrium, PB = population-based, SNP = single nucleic polymorphism, Y = yes.

3.2. Quantitative synthesis

3.2.1. rs2070744.

Nine studies comprising 2015 cases and 1676 controls were included in the meta-analysis examining the association between the eNOS gene polymorphism (rs2070744) and male infertility. Results showed significant associations with male sterility risk in 5 genetic models: allele contrast C vs. T (OR, 1.48; 95% CI, [1.19–1.85]; P < .001), homozygote model CC vs. TT (OR, 2.59; 95% CI, [1.40–4.80]; P = .002), heterozygote model CT vs. TT (OR, 1.17; 95% CI, [1.00–1.38]; P = .0048), recessive model CC vs. TC + TT (OR, 2.50; 95% CI, [1.35–4.62]; P = .003), and dominant model CC + TC vs. TT (OR,1.41; 95% CI, [1.21–1.64]; P < .001). All studies included in the meta-analysis adhered to HWE (as shown in Fig. 2, Table 2, and Supplementary Figure S1, Supplemental Digital Content, http://links.lww.com/MD/J113).

Figure 2.

Figure 2.

Forest plots of the eNOS rs2070744 polymorphism under different genetic models. eNOS = endothelial nitric oxide synthase.

Table 2.

Meta-analysis of eNOS polymorphisms.

rs2070744 (C: Wild type, T: Mutant type)
Model Study n OR 95% CI P value I 2 P value (Egger test)
C vs. T Overall 9 1.4841 [1.1905; 1.8502] .000448 0.6625 .2686
Asian 3 1.4014 [1.1057; 1.7763] .00526 0.1565 .574
Caucasian 5 1.6067 [1.1431; 2.2585] .006342 0.7088 .2636
Mixed 1 1.1869 [0.8953; 1.5734] .233578 NA NA
CC vs. TT Overall 8 2.5902 [1.3990; 4.7955] .002459 0.65 .48
Asian 2 2.3711 [0.6047; 9.2982] .215583 0 .7456
Caucasian 5 2.9865 [1.3191; 6.7619] .008686 0.6945 .3941
Mixed 1 1.5595 [0.8607; 2.8256] .14284 NA NA
CT vs. TT Overall 9 1.1746 [1.0012; 1.3780] .048317 0.342 .9044
Asian 3 1.3805 [1.0683; 1.7839] .013686 0.4838 .782
Caucasian 5 1.0845 [0.8590; 1.3691] .495308 0.2901 .8719
Mixed 1 0.9837 [0.6440; 1.5025] .939257 NA NA
CC vs. CT + TT Overall 8 2.5005 [1.3530; 4.6213] .003449 0.6808 .454
Asian 2 2.3147 [0.5908; 9.0685] .228353 0 .7243
Caucasian 5 2.8322 [1.2437; 6.4493] .013158 0.7234 .3596
Mixed 1 1.5736 [0.9107; 2.7193] .104233 NA NA
CC + CT vs. TT Overall 9 1.4120 [1.2125; 1.6444] 9.06E-06 0.3155 .6195
Asian 3 1.4135 [1.0979; 1.8198] .00726 0.3843 .6393
Caucasian 5 1.5188 [1.2219; 1.8877] .000166 0.3867 .5334
Mixed 1 1.1017 [0.7391; 1.6421] .634499 NA NA
rs1799983 (T: Wild type, G: Mutant type)
 Model Study n OR 95% CI P value I 2 P value (Egger test)
 T vs. G Overall 12 1.4069 [1.0110; 1.9577] .042857 0.8894 .5081
Asian 4 1.2335 [1.0531; 1.4449] .009306 0 .4008
Caucasian 7 1.5651 [0.8508; 2.8791] .14978 0.9211 .1919
Mixed 1 1.1537 [0.8614; 1.5452] .337482 NA NA
 TT vs. GG Overall 12 2.0848 [0.8989; 4.8355] .086966 0.8232 .816
Asian 4 2.0436 [1.0419; 4.0084] .03757 0 .85
Caucasian 7 2.2270 [0.5091; 9.7426] .287656 0.8938 .7656
Mixed 1 1.0433 [0.5564; 1.9563] .894863 NA NA
 TG vs. GG Overall 12 1.2990 [0.9515; 1.7734] .099579 0.773 .5984
Asian 4 1.1887 [0.9951; 1.4200] .05671 0 .4002
Caucasian 7 1.5074 [0.8311; 2.7342] .176723 0.8268 .3825
Mixed 1 0.7222 [0.3793; 1.3749] .321757 NA NA
 TT vs. TG + GG Overall 12 2.0007 [1.0267; 3.8990] .04162 0.7733 .6073
Asian 4 1.9615 [1.0019; 3.8401] .049355 0 .7763
Caucasian 7 2.0610 [0.5921; 7.1736] .255763 0.8686 .9476
Mixed 1 1.3423 [0.9150; 1.9691] .132132 NA NA
 TT + TG vs. GG Overall 12 1.4235 [0.9975; 2.0313] .051637 0.8447 .5672
Asian 4 1.2268 [1.0306; 1.4604] .021502 0 .3628
Caucasian 7 1.6611 [0.8687; 3.1763] .124938 0.8753 .2311
Mixed 1 0.8861 [0.4855; 1.6171] .693607 NA NA
rs61722009 (4a: Wild type, 4b: Mutant type)
 Model Study n OR 95% CI P value I 2 P value (Egger test)
4a vs. 4b Overall 6 1.4960 [0.9398; 2.3812] .089448 0.8943 .2375
Asian 3 1.5092 [1.1892; 1.9153] .000712 0.4725 .0391
Caucasian 2 1.8276 [0.5776; 5.7826] .304881 0.9481 NA
Mixed 1 0.8938 [0.6422; 1.2441] .50571 NA NA
4a4a vs. 4b4b Overall 6 2.5615 [0.6999; 9.3750] .155353 0.8047 .5956
Asian 3 2.2155 [0.7975; 6.1550] .127051 0 .9933
Caucasian 2 7.1617 [0.5853; 87.6350] .123383 0.8641 NA
Mixed 1 0.5462 [0.2236; 1.3342] .184456 NA NA
4a4b vs. 4b4b Overall 6 1.3620 [0.8691; 2.1345] .177738 0.8073 .0562
Asian 3 1.4978 [1.1524; 1.9468] .002526 0.5065 .3147
Caucasian 2 1.5212 [0.4709; 4.9141] .483237 0.9262 NA
Mixed 1 0.5101 [0.2029; 1.2827] .152512 NA NA
4a4a vs.4a4b + 4b4b Overall 6 2.5708 [0.9055; 7.2992] .076159 0.7683 .2023
Asian 3 2.0926 [0.7540; 5.8079] .156272 0 .9261
Caucasian 2 6.1623 [0.7645; 49.6695] .087674 0.8067 NA
Mixed 1 0.9736 [0.6538; 1.4498] .895288 NA NA
4a4a + 4a4b vs. 4b4b Overall 6 1.4435 [0.8694; 2.3966] .15591 0.8589 .0485
Asian 3 1.5334 [1.1870; 1.9808] .001067 0.5028 .1839
Caucasian 2 1.7810 [0.4818; 6.5844] .386924 0.9453 NA
Mixed 1 0.5333 [0.2210; 1.2870] .161953 NA NA

CI = confidence interval, eNOS = endothelial nitric oxide synthase, n = number, NA = not applicable, OR = odds ratio.

3.2.2. rs1799983.

A total of 12 randomized controlled trials (including 2780 cases and 2319 controls) were included in the meta-analysis of the rs1799983 polymorphism and its association with male infertility. The results indicated a significant correlation in 2 genetic models (allele contrast [T vs. G: OR, 1.41; 95% CI, (1.01–1.96); P = .043]; recessive model [TT vs. TG + GG: OR, 2.00; 95% CI, (1.03–3.90); P = .042]) as shown in Figure 3, Table 2 and Supplementary Figure S2, Supplemental Digital Content, http://links.lww.com/MD/J114. Subgroup analysis was conducted to investigate the effect of ethnicity, which revealed a differential correlation with Asians (allele contrast (T vs. G: OR, 1.23; 95% CI, [1.05–1.44]; P = .009); homozygote model (TT vs. GG: OR, 2.04; 95% CI, [1.04–4.00]; P = .04); recessive model (TT vs. TG + GG: OR, 1.96; 95% CI, [1.001–3.84]; P = .0493); dominant model (TG + TT vs. GG: OR,1.22; 95% CI, [1.03–1.46]; P = .021)) as shown in Supplementary Figure S4(a), Supplemental Digital Content, http://links.lww.com/MD/J115 and Table 2.

Figure 3.

Figure 3.

Forest plots of the eNOS rs1799983 polymorphism under different genetic models. eNOS = endothelial nitric oxide synthase.

3.2.3. rs61722009.

Six studies involving 1723 infertility patients and 1466 healthy controls were included. There were no difference between the male infertility and 5 genetic models of the rs61722009 (allele contrast [4a vs. 4b: OR, 1.47; 95% CI, (.94–2.38); P = .09]; homozygote model [4a4a vs. 4b4b: OR, 2.56; 95% CI, (.70–9.38); P = .16]; heterozygote model [4a4b vs. 4b4b: OR, 1.36; 95% CI, (.87–2.13); P = .18]; recessive model [4a4a vs. 4a4b + 4b4b = OR, 2.57; 95% CI, (.91–7.30); P = .08]; dominant model [4a4a + 4a4b vs. 4b4b = OR,1.44; 95% CI, (.87–2.40); P = .16]). While rs61722009 had a significant difference associated with the Asians in allele contrast (OR = 1.51; 95% CI, [1.19–1.92]; P = .0007), the heterozygote model (OR = 1.50; 95% CI, [1.15–1.95]; P = .003) and dominant model (OR = 1.53; 95 CI%, [1.19–1.98]; P = .001) through the subgroup analysis (as shown in Fig. 4, Supplementary Figure S3, Supplemental Digital Content, http://links.lww.com/MD/J116, Supplementary Figure S4(b), Supplemental Digital Content, http://links.lww.com/MD/J115 and Table 2).

Figure 4.

Figure 4.

Forest plots of the eNOS rs61722009 polymorphism under different genetic models. eNOS = endothelial nitric oxide synthase.

3.3. Sensitivity analysis and publication bias

A sensitivity analysis was conducted to evaluate the impact of individual studies on the overall results, and the findings indicated that the pooled ORs for the 3 polymorphisms were not significantly affected (as shown in Fig. 5). Publication bias was assessed using Egger regression tests, and the results suggested no evidence of publication bias (as displayed in Table 2 and Supplementary Figures S1–3, Supplemental Digital Content, http://links.lww.com/MD/J113; http://links.lww.com/MD/J114; http://links.lww.com/MD/J116).

Figure 5.

Figure 5.

Sensitivity analysis of eNOS polymorphisms (rs2070744, rs1799983, rs61722009) in allele contrast and recessive model. eNOS = endothelial nitric oxide synthase.

3.4. In-silico analysis using GTEx website

Based on the result of the GTEx database, we observed that the polymorphism of the eNOS (rs1799983) reduce the expression of mRNA at the testicular (P = .036), while the rs2070744 had no difference (P = .16) (Fig. 6A). So far rs61722009 has not been introduced in GTEx database.

Figure 6.

Figure 6.

(A) eNOS mRNA expression by eQTL analysis in Human tissues based on GTEx database (rs2070744, rs1799983 in testcle). (B) TSA for eNOS 3 polymorphisms (rs2070744, rs1799983, rs61722009) under the allele contrast model. eNOS = endothelial nitric oxide synthase, TSA = trial sequential analysis.

3.5. TSA

To assess random errors in the 3 polymorphisms, we used TSA beta 0.9. In rs2070744, the traditional and TSA boundaries are crossed by the cumulative Z-curve, indicating that even if the test sequence monitoring boundary does not reach the expected value, further tests are not required to draw a positive conclusion in advance. In rs1799983, the traditional boundary value is only crossed by the Z-curve, but the TSA boundary value is not crossed, and the test sequence monitoring boundary does not meet the expected information content, indicating that the traditional meta-analysis might have obtained false positive conclusions, and in fact, more studies need to be included to determine the conclusion. And in rs61722009, the cumulative Z-curve did not cross the traditional and TSA boundaries, indicating that further studies are required to draw a conclusion (Fig. 6B). The Preferred Reporting Items for Systematic Reviews and Meta-analysis checklist is reported in Supplementary Table S1, Supplemental Digital Content, http://links.lww.com/MD/J117.

4. Discussion

Mutations in genes are becoming more prevalent in many diseases.[17] In recent years, many studies had found eNOS may play an important character in male infertility.[18] Song et al[19] have found both rs2070744 and rs61722009 as risk genotypes for male infertility in both Asian and Caucasian populations. Furthermore, no difference was observed in the eNOS gene polymorphism of rs1799983 in relation to male infertility. And Chang et al[20] suggested that rs2070744 and rs6172009 of eNOS are the risk factors for developing male infertility in Asian and Caucasian populations. In addition, rs1799983 and rs2070744 may have an influence on semen quality. However, the results might be controversial due to incomplete data or obvious heterogeneity. Consequently, this updated meta-analysis was performed to demonstrate the association between genetic variations in the eNOS gene and male infertility.

This meta-analysis included a total of 13 studies with 6518 cases and 5461 controls and aimed to investigate the association between 3 polymorphisms (rs2070744, rs1799983, and rs61722009) and the risk of male infertility. The results showed that rs2070744 was significantly associated with the risk of male infertility in 5 genetic models among mixed, Asian, and Caucasian populations. Additionally, rs61722009 was associated with the risk of male infertility in Asians. Subgroup analysis revealed differences in rs1799983 related to male infertility. These findings suggest that genetic variants in eNOS may play a role in the susceptibility to male infertility. However, further studies are needed to better understand the underlying mechanisms involved.

Previous studies have suggested that the eNOS rs2070744 polymorphism is a risk factor for male infertility in both Asian and Caucasian populations. Our meta-analysis confirmed this association and showed significant heterogeneity among the 5 genetic models, which may be due to differences in ethnicity. Therefore, we conducted a subgroup meta-analysis by ethnicity and found that rs2070744 was a risk factor for male infertility in the allelic contrast, heterozygote model, and dominant model among Asian populations. Additionally, TSA analysis indicated that further case-controls are not necessary to confirm this result.

In contrast to previous studies, our meta-analysis found that eNOS rs1799983 was significantly related to male infertility in 2 genetic models. Interestingly, subgroup meta-analysis stratified by ethnicity also showed consistent results. However, TSA analysis and the GTEx database suggested that the traditional meta-analysis might have obtained false positive conclusions and that rs1799983 actually reduces the expression of mRNA in the testes. Therefore, further studies are needed to confirm the association between rs1799983 and male infertility.

Regarding eNOS rs61722009, few studies reported its relationship with the risk of male infertility, especially after excluding studies with high heterogeneity and including new studies with lower heterogeneity. We have found the associations only with the Asian populations. Combines with the small sample size nevertheless, the findings from the current analysis are inconclusive according to the results of the TSA.

The eNOS gene expression can be regulated by transcription, translation, protein phosphorylation, and other aspects, which have been confirmed by previous studies.[21] Hypoxia and strenuous exercise can upregulate eNOS expression levels. In our research, rs2070744 can raise DNA susceptibility in all 5 genetic models because the T786C variant is a cytosine (C) replacement of the thymine nucleotide (T) at the 786 loci of the eNOS.[22] This leads to structural changes in the protein that alter the activity of eNOS. The increasing expression of eNOS leads to elevated production of NO, which directly affects the function and viability of sperm.[23]

In the research, we performed a systematic and comprehensive search to obtain reliable results. We used sensitivity analysis, Egger tests to evaluate the quality of the included studies. Nonetheless, there are some limitations in this meta-analysis. First, only 3 ethnic groups (Asian, Caucasian, and Mixed) were included in this study. Second, the sample size of rs1799983 and rs61722009 was relatively small. Third, the language of including studies was only English, which may influence the association between them. Fourth, the number of case-controls was too small which might result in great errors.[24,25] More large sample size case-control studies of various ethnicities are needed to investigate the functions of eNOS polymorphisms.

5. Conclusion

The results of this meta-analysis suggest that eNOS rs2070744 and rs1799983 are associated with the risk of male infertility, and eNOS rs61722009 is associated with the risk of male infertility in Asian population. However, further well-designed case-control studies are needed to confirm these findings.

Author contributions

Data curation: Zhihai Teng, Hu Wang, Fengran Guo, Zhenwei Han, Yaxuan Wang.

Formal analysis: Zhihai Teng, Hu Wang, Zhenwei Han, Yaxuan Wang.

Funding acquisition: Zhenwei Han.

Methodology: Fengran Guo, Zhenwei Han.

Project administration: Zhihai Teng, Zhenwei Han.

Software: Zhihai Teng, Hu Wang, Fengran Guo, Yaxuan Wang.

Writing – original draft: Zhihai Teng, Hu Wang.

Writing – review & editing: Zhihai Teng, Hu Wang, Zhenwei Han, Yaxuan Wang.

Supplementary Material

medi-102-e33993-s001.pdf (155.6KB, pdf)
medi-102-e33993-s003.pdf (36.8KB, pdf)
medi-102-e33993-s004.pdf (138.9KB, pdf)
medi-102-e33993-s005.pdf (216.6KB, pdf)

Abbreviations:

CI
confidence interval
eNOS
endothelial nitric oxide synthase
HWE
Hardy–Weinberg equilibrium
NOS
nitric oxide synthase
OR
odds ratio
TSA
trial sequential analysis

ZT and HW contributed equally to this work.

This work has been supported by Hebei Province Natural Science Foundation (H2020206146).

The authors have no conflicts of interest to disclose.

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

Supplemental Digital Content is available for this article.

How to cite this article: Teng Z, Wang H, Guo F, Han Z, Wang Y. eNOS polymorphisms on male infertility: An updated systematic review and meta-analysis. Medicine 2023;102:24(e33993).

Contributor Information

Zhihai Teng, Email: Tengzhihai1988@126.com.

Hu Wang, Email: wangyaxuan87@126.com.

Fengran Guo, Email: Guofengran2022@163.com.

Zhenwei Han, Email: hanzhenwei@hebmu.edu.cn.

References

  • [1].Coutton C, Satre V, Arnoult C, et al. Genetics of male infertility: the new players [in French]. Med Sci (Paris). 2012;28:497–502. Genetique de l'infertilite masculine: les nouveaux acteurs. [DOI] [PubMed] [Google Scholar]
  • [2].Hajizadeh YS, Emami E, Nottagh M, et al. Effects of interleukin-1 receptor antagonist (IL-1Ra) gene 86 bp VNTR polymorphism on recurrent pregnancy loss: a case-control study. Horm Mol Biol Clin Investig. 2017;30:20170010. [DOI] [PubMed] [Google Scholar]
  • [3].Sun XH, Zhu YY, Wang L, et al. The Catsper channel and its roles in male fertility: a systematic review. Reprod Biol Endocrinol. 2017;15:65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Poongothai J, Gopenath TS, Manonayaki S. Genetics of human male infertility. Singapore Med J. 2009;50:336–47. [PubMed] [Google Scholar]
  • [5].Agarwal A, Sharma RK, Desai NR, et al. Role of oxidative stress in pathogenesis of varicocele and infertility. Urology. 2009;73:461–9. [DOI] [PubMed] [Google Scholar]
  • [6].Mahfouz R, Sharma R, Sharma D, et al. Diagnostic value of the total antioxidant capacity (TAC) in human seminal plasma. Fertil Steril. 2009;91:805–11. [DOI] [PubMed] [Google Scholar]
  • [7].Zini A, O’Bryan MK, Magid MS, et al. Immunohistochemical localization of endothelial nitric oxide synthase in human testis, epididymis, and vas deferens suggests a possible role for nitric oxide in spermatogenesis, sperm maturation, and programmed cell death. Biol Reprod. 1996;55:935–41. [DOI] [PubMed] [Google Scholar]
  • [8].Ambulkar PS, Sigh R, Reddy M, et al. Genetic risk of Azoospermia Factor (AZF) microdeletions in idiopathic cases of azoospermia and oligozoospermia in central Indian population. J Clin Diagn Res. 2014;8:88–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].Lewis SE, Donnelly ET, Sterling ES, et al. Nitric oxide synthase and nitrite production in human spermatozoa: evidence that endogenous nitric oxide is beneficial to sperm motility. Mol Hum Reprod. 1996;2:873–8. [DOI] [PubMed] [Google Scholar]
  • [10].Koppenol WH, Traynham JG. Say NO to nitric oxide: nomenclature for nitrogen- and oxygen-containing compounds. Methods Enzymol. 1996;268:3–7. [DOI] [PubMed] [Google Scholar]
  • [11].Forstermann U, Closs EI, Pollock JS, et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 1994;23(6 Pt 2):1121–31. [DOI] [PubMed] [Google Scholar]
  • [12].Sharma D, Trivedi SS, Bhattacharjee J. Oxidative stress and eNOS (Glu298Asp) gene polymorphism in preeclampsia in Indian population. Mol Cell Biochem. 2011;353:189–93. [DOI] [PubMed] [Google Scholar]
  • [13].Narne P, Ponnaluri KC, Siraj M, et al. Polymorphisms in oxidative stress pathway genes and risk of diabetic nephropathy in South Indian type 2 diabetic patients. Nephrology (Carlton). 2014;19:623–9. [DOI] [PubMed] [Google Scholar]
  • [14].Martorell-Marugan J, Toro-Dominguez D, Alarcon-Riquelme ME, et al. MetaGenyo: a web tool for meta-analysis of genetic association studies. BMC Bioinf. 2017;18:563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Gibson G. Human genetics. GTEx detects genetic effects. Science. 2015;348:640–1. [DOI] [PubMed] [Google Scholar]
  • [16].Xie S, Shan XF, Shang K, et al. Relevance of LIG4 gene polymorphisms with cancer susceptibility: evidence from a meta-analysis. Sci Rep. 2014;4:6630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17].Hotaling J, Carrell DT. Clinical genetic testing for male factor infertility: current applications and future directions. Andrology. 2014;2:339–50. [DOI] [PubMed] [Google Scholar]
  • [18].Chavoshi R, Khalifeh Zadeh Kaleybar SB. Association of nitric oxide synthase 3 gene rs1799983 G/T polymorphism with idiopathic asthenozoospermia in Iranian Azeri males: a case-control study. Horm Mol Biol Clin Investig. 2020;41:20200014. [DOI] [PubMed] [Google Scholar]
  • [19].Song P, Zou S, Chen T, et al. Endothelial nitric oxide synthase (eNOS) T-786C, 4a4b, and G894T polymorphisms and male infertility: study for idiopathic asthenozoospermia and meta-analysis. Biol Reprod. 2015;92:38. [DOI] [PubMed] [Google Scholar]
  • [20].Chang J, Pan F, Tang Q, et al. eNOS gene T786C, G894T and 4a4b polymorphisms and male infertility susceptibility: a meta-analysis. Andrologia. 2017;49:e12646. [DOI] [PubMed] [Google Scholar]
  • [21].Chatterjee A, Catravas JD. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vasc Pharmacol. 2008;49:134–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Barbosa AM, Silva KSF, Lagares MH, et al. Atherosclerosis: analysis of the eNOS (T786C) gene polymorphism. Genet Mol Res. 2017;16:gmr16039708. [DOI] [PubMed] [Google Scholar]
  • [23].Balercia G, Moretti S, Vignini A, et al. Role of nitric oxide concentrations on human sperm motility. J Androl. 2004;25:245–9. [DOI] [PubMed] [Google Scholar]
  • [24].Muti ND, Tirabassi G, Buldreghini E, et al. Synergistic effect of androgen receptor (CAG repeat length) and endothelial nitric oxide synthase (Glu298Asp variant) gene polymorphisms on seminal parameters in men with idiopathic oligoasthenozoospermia. Endocrine. 2014;47:322–4. [DOI] [PubMed] [Google Scholar]
  • [25].Faure C, Leveille P, Dupont C, et al. Are superoxide dismutase 2 and nitric oxide synthase polymorphisms associated with idiopathic infertility? Antioxid Redox Signal. 2014;21:565–9. [DOI] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES